Anti-IgE or Anti-IL5: That Is the Question

J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):782-784. doi: 10.1016/j.jaip.2017.10.025. Epub 2017 Nov 14.

Authors

Elliot Israel¹, Reynold A Panettieri Jr²

Affiliations

¹ Divisions of Pulmonary and Critical Care Medicine and Allergy, Immunology and Rheumatology, Department of Medicine, Harvard Medical School, Brigham & Women's Hospital, Boston, Mass.
² Rutgers Institute for Translational Medicine and Science, Rutgers Biomedical and Health Sciences, Rutgers University, New Brunswick, NJ. Electronic address: rp856@rbhs.rutgers.edu.

PMID: 29150253
DOI: 10.1016/j.jaip.2017.10.025

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Antibodies, Anti-Idiotypic / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Asthma / drug therapy*
Bronchodilator Agents / therapeutic use
Child
Female
Humans
Interleukin-5 / antagonists & inhibitors*
Interleukin-5 / immunology
Male
Middle Aged
Young Adult

Substances

Adrenal Cortex Hormones
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal
Bronchodilator Agents
Interleukin-5
anti-IgE antibodies